Patent Assignment
Reel/Frame 021339/0344
Assignment of Assignor's Interest
Recorded: 2008-08-06
Pages: 13
Assignors
LIGAND PHARMACEUTICALS INCORPORATED
Executed: 2006-10-23
SERAGEN, INC.
Executed: 2006-10-23
Assignee
EISAI INC.
100 TICE BLVD., WOODCLIFF LAKE, NEW JERSEY, 07677
Covered Properties
(42)
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Application:
07/809,980 →
Use of Cell Surface Receptor Targeted Molecules for the Treatment of Viral Diseases
Application:
07/914,492 →
Compounds Having Selective Activity for Retinold X Receptors Including New Bicyclic Derivatives, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
07/944,783 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/003,223 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/027,747 →
Method for Stereospecific Synthesis of 9-Cis Retinoic Acid and Related Compounds
Application:
08/052,040 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/052,050 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/052,051 →
Use of Cell Surface Receptor Targeted Molecules for the Treatment of Viral Diseases
Application:
08/053,557 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
7,655,699 →
Application:
08/141,246 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/141,496 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/141,914 →
Methods for Stereospecific Synthesis of Polyene Compounds
Patent:
5,567,855 →
Application:
08/230,939 →
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Application:
08/244,857 →
Use of Cell Surface Receptor Targeted Molecules for the Treatment of Viral Diseases
Application:
08/289,128 →
Methof of Cell Surface Receptor Targeted Molecules for Treatment of Viral Diseases
Patent:
6,074,636 →
Application:
08/465,541 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
5,962,731 →
Application:
08/472,784 →
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Patent:
5,968,989 →
Application:
08/472,817 →
Method for in Vivo Modulation of Non-Malignant Skin-Related Processes with 9-Cis Retinoic Acid
Patent:
5,932,622 →
Application:
08/475,174 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Application:
08/479,920 →
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Patent:
6,506,917 →
Application:
08/480,967 →
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Patent:
6,992,108 →
Application:
08/482,737 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
5,780,676 →
Application:
08/485,386 →
Treating Niddm with Rxr Agonists
Patent:
6,028,052 →
Application:
08/710,309 →
Methods for Stereospecific Synthesis of Polyene Compounds
Patent:
5,817,845 →
Application:
08/731,069 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
6,043,279 →
Application:
08/799,396 →
Treating Niddm with Rxr Agonists
Patent:
5,972,881 →
Application:
08/979,725 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
6,610,883 →
Application:
09/115,615 →
Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors
Patent:
6,320,074 →
Application:
09/179,674 →
Treating Niddm with Rxr Agonists
Patent:
6,228,862 →
Application:
09/309,370 →
Methods and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using Rxr Modulators
Application:
09/327,117 →
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Treating NIDDM with RXR agonists
Patent:
6,316,404 →
Application:
09/745,681 →
Treating Niddm with Rxr Agonists
Methods and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using Rxr Modulators
Means for the Modulation of Processes Mediated by Retinoid Receptors and Compounds Useful Therefor
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Application:
11/256,501 →
Publication:
US 2006/0211768
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
Application:
11/300,039 →
Publication:
US 2006/0106072
Compounds and Methods for Treating Obesity
Application:
60/003,869 →
Treating Niddm with Rxr Agonists
Application:
60/018,318 →
Treating Niddm with Rxr Agonists
Application:
60/021,839 →
Methods and Pharmaceutical Compositions for the Treatment of Anti-Estrogen Resistant Breast Cancer Using Rxr Modulators
Application:
60/089,104 →
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Feb 21, 1992
From: EVANS, RONALD M.; MANGELSDORF, DAVID J.
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE
Reel/Frame 006017/0986 →
Assignment of Assignors Interest.
Feb 21, 1992
From: EICHELE, GREGOR; THALLER, CHRISTINA
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 006017/0978 →
Assignment of Assignors Interest.
Feb 21, 1992
From: HEYMAN, RICHARD A.; BOEHM, MARCUS F.
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 006017/0982 →
Assignment of Assignors Interest.
Oct 27, 1992
From: BOEHM, MARCUS F.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 006284/0126 →
Assignment of Assignors Interest.
Apr 30, 1993
From: BOEHM, MARCUS E.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 006518/0517 →
Assignment of Assignor's Interest
May 17, 1993
From: BOEHM, MARCUS F.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 006545/0868 →
Assignment of Assignor's Interest
Jul 29, 1993
From: WHITE, STEVEN K.; HWANG, CHAN K.; WINN, DAVID T.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 006624/0550 →
Assignment of Assignor's Interest
Jul 29, 1993
From: BOEHM, MARCUS F.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 006631/0540 →
Assignment of Assignor's Interest
Dec 13, 1993
From: BOEHM, MARCUS F.; HEYMAN, RICHARD A.; ZHI, LIN; KOCH, STACIE C.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 006796/0747 →
Assignment of Assignor's Interest
Dec 13, 1993
From: BOEHM, MARCUS F.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 006797/0190 →
Assignment of Assignor's Interest
Dec 20, 1993
From: BOEHM, MARCUS; HEYMAN, RICHARD A.; ZHI, LIN; HWANG, CHAN KOU
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 006811/0196 →
Assignment of Assignor's Interest
Jun 14, 1994
From: EICHELE, GREGOR; THALLER, CHRISTINA
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 007128/0042 →
Assignment of Assignor's Interest
Jun 14, 1994
From: EVANS, RONALD M.; MANGELSDORF, DAVID J.
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE
Reel/Frame 007128/0050 →
Assignment of Assignor's Interest
Jun 14, 1994
From: WHITE, STEVEN K.; HWANG, CHAN KOU; WINN, DAVID T.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 007022/0993 →
Assignment of Assignor's Interest
Jun 14, 1994
From: HEYMAN, RICHARD A.; BOEHM, MARCUS F.
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 007128/0046 →
Assignment of Assignor's Interest
Jan 13, 1997
From: HEYMAN, RICHARD A.; CESARIO, ROSEMARY; MUKHERJEE, RANJAN
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 008361/0395 →
Assignment of Assignor's Interest
Nov 26, 1997
From: HEYMAN, RICHARD A.; CESARIO, ROSEMARY; MUKHERJEE, RANJAN
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 008846/0168 →
Assignment of Assignor's Interest
Oct 29, 1999
From: LAMPH, WILLIAM W.; BISCHOFF, ERIC D.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INC.
Reel/Frame 010342/0598 →
Assignment of Assignor's Interest
May 9, 2003
From: BOEHM, MARCUS F.; HEYMAN, RICHARD A.; ZHI, LIN; HWANG, CHAN KOU (JACK)
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 014047/0212 →
Assignment of Assignor's Interest
Mar 5, 2013
From: EISAI, INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 029928/0839 →
Security Interest
Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →